RxDoctor Payments Data

April Crunk, PA

Physician Assistant · Birmingham, ALNPI 1396002671

Payments from drug & device makers

$531in general payments, 2019–2025

Across 12 payments — averaging $44.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tempus AI, Inc$120
  • Procept Biorobotics Corporation$117
  • Axonics, Inc.$85
  • Sumitomo Pharma America, Inc.$77
  • Abbott$50
  • Hollister Incorporated$31
  • plus $52 from 2 others

What the payments were for

  • Food & beverage$531100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$531 in reported general payments places this provider in the 55th percentile of 846 physician assistant providers in Alabama.

See all physician assistant providers in Alabama

Medicare billing

Part B allowed, 2024
$61,389
Medicare patients
419
Services billed
1,124

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron66$36,888
GemtesaVibegron18$13,137
Tamsulosin Hcl321$5,219
Oxybutynin Chloride ErOxybutynin Chloride93$1,999
Tadalafil36$1,565
Alfuzosin Hcl ErAlfuzosin Hcl70$1,501
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst48$1,090
Ciprofloxacin Hcl284$963
Finasteride49$742
Silodosin20$650
Oxybutynin Chloride26$553
Testosterone Cypionate12$479
Dutasteride15$431
Doxazosin Mesylate16$255
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim24$65

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$77$13,13718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 846 physician assistant providers in Alabama.

Other physician assistant in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →